Plan B OTC Submission Fails On Lack Of Data In Teens
This article was originally published in The Tan Sheet
Executive Summary
Barr Labs will continue to work with FDA toward approval of emergency contraceptive Plan B (levonorgestrel .75 mg) for OTC use, the company said in a May 6 statement